EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis

Christina Mitteldorf iD

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025

DOI: 10.1111/ddg.15773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Christina Mitteldorf. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Drug Eruptions, Exanthema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mogamulizumab‐associated rash (MAR) is a frequent side‐effect of a treatment with Mogamulizumab that poses diagnostic challenges. Patients and methods We reviewed our database for novel histological patterns in MAR.

Results

Four new histological patterns were identified: (1) A pagetoid pattern, which could be mistaken for CD8 + aggressive epidermotropic cytotoxic T‐cell lymphoma. (2) A lupus erythematosus‐like pattern, characterized vacuolar interface dermatitis, deep perivascular lymphocytic infiltrate, interstitial mucin deposits, and clusters of CD123 + plasmacytoid dendritic cells. (3) Pustular folliculitis/acneiform pattern, which may clinically and histologically resemble acne. (4) A combined pattern with MAR coexisting with residual or new infiltrates of the original/underlying lymphoma. Previously described main patterns were reproducible. The folliculotropic and MF‐like epidermotropic infiltrate should be also mentioned as separate patterns. Immunohistochemistry and the comparison with the original lymphoma remain crucial for diagnosis, especially a shift towards CD8 + cells, CD7 expression by infiltrating lymphocytes, and an increased number of histiocytes across all MAR patterns.

Conclusions

MAR presents a range of histological patterns that mimic other conditions, underscoring the importance of careful histopathological and immunohistochemical analysis and clinicopathological correlation for accurate diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedDrug EruptionsExanthemaHumansDiagnosis, DifferentialMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

CD8+ lymphocytic infiltratehistiocyteshistopathologic patternsmogamulizumab‐associated rashtumor microenvironment

Substanzen

mogamulizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, University Medical Centre Göttingen, Göttingen, Germany.

ORCID-Profile: Christina Mitteldorf

Zitieren

APA

Mitteldorf, C. (2025). Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15773

Vancouver

Mitteldorf C. Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15773

BibTeX
@article{Mitteldorf2025,
  author = {Mitteldorf, Christina},
  title = {Novel and recurrent histopathologic patterns of mogamulizumab‐associated rash: diagnostic implications and insights for accurate diagnosis},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2025},
  doi = {10.1111/ddg.15773}
}
Kostenlos starten →